Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Raibulet NK"'
Autor:
Bajpai SK, Cambron-Mellott MJ, Will O, Poon JL, Wang Q, Mitchell BD, Peck EY, Babrowicz J, Raibulet NK, Child CJ, Beusterien K
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 15, Pp 3601-3615 (2022)
Sanjay K Bajpai,1 M Janelle Cambron-Mellott,2 Oliver Will,2 Jiat-Ling Poon,1 Qianqian Wang,1 Beth D Mitchell,1 Eugenia Y Peck,2 Jane Babrowicz,2 Nedina K Raibulet,1 Christopher J Child,1 Kathleen Beusterien2 1Eli Lilly and Company, Indianapolis, IN,
Externí odkaz:
https://doaj.org/article/15c5698a3729450696836ee6af274ccc
Autor:
Bajpai SK; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Cambron-Mellott MJ; Kantar Health, New York, NY, USA., Peck E; Kantar Health, New York, NY, USA., Poon JL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Wang Q; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Mitchell BD; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Babrowicz J; Kantar Health, New York, NY, USA., Child CJ; Lilly Diabetes, Surrey, United Kingdom., Raibulet NK; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Beusterien K; Kantar Health, New York, NY, USA. Electronic address: Kathleen.beusterien@kantarhealth.com.
Publikováno v:
Clinical therapeutics [Clin Ther] 2019 Oct; Vol. 41 (10), pp. 2073-2089.e6. Date of Electronic Publication: 2019 Sep 13.